NCT00123955
PIE II: Pharmacological Intervention in the Elderly II
See it on ClinicalTrials.gov ↗80 people
80%
20%
64 womenmiddle line = equal numbers16 men
- Phase
- PHASE3
- Paid for by
- Wake Forest University
- Finished
- 2012-12
- Health conditions
- Diastolic Heart Failure, Heart Failure, Congestive
- Who could join
- Anyone
- Ages
- 60 Years – no maximum
- Average age
- mean 70.8 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Renal insufficiency”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Valvular heart disease”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Psychiatric disease (uncontrolled major psychoses, depression, dementia, or personality disorder)”
- No cancer
Women with current or past cancer were turned away.
“Cancer or other noncardiovascular conditions with life expectancy less than 2 years”
Study titles and rules are shown in their original English.